Douglas Johns

Clinical Pharmacology Lead
Merck Research Laboratories

Disclosure information not submitted.

Presentation(s):

• 11 - The development of the oral macrocycle, MK-0616, for treating hypercholesterolemia

  Monday, July 14, 2025
  1:30 PM – 2:00 PM EDT